These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9004108

  • 1. Evaluation of enalapril/diltiazem ER in hypertensive patients with coexisting renal dysfunction. Enalapril/Diltiazem ER in Hypertensive Renal Disease Group.
    Hricik DE, Levine BS, Adrogue HJ, Weinberg MS, Goldstein R.
    J Hum Hypertens; 1996 Nov; 10(11):769-74. PubMed ID: 9004108
    [Abstract] [Full Text] [Related]

  • 2. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W, Cohen JD, Wolfson P, Davis A, Green S.
    Pharmacotherapy; 1997 Nov; 17(1):107-12. PubMed ID: 9017770
    [Abstract] [Full Text] [Related]

  • 3. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension.
    Cushman WC, Cohen JD, Jones RP, Marbury TC, Rhoades RB, Smith LK.
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):23-30. PubMed ID: 9504446
    [Abstract] [Full Text] [Related]

  • 5. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 Jan; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 6. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
    Weir RJ, Lee PS, Clegg DS, Hemingray S, Belgrave GP, Walter E.
    Br J Clin Pract; 1994 Jan; 48(6):287-92. PubMed ID: 7848788
    [Abstract] [Full Text] [Related]

  • 7. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
    Bernadet-Monrozies P, Poilleux E, Suc JM.
    Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
    [Abstract] [Full Text] [Related]

  • 9. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension.
    Weir MR, Haynie R, Vertes V, Pinson R, Kong BW, Jenkins P, Lavin PT.
    Clin Ther; 1990 Oct; 12(6):473-81. PubMed ID: 2289216
    [Abstract] [Full Text] [Related]

  • 11. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 12. The long-term tolerability of enalapril in hypertensive patients with renal impairment.
    Keane WF, Polis A, Wolf D, Faison E, Shahinfar S.
    Nephrol Dial Transplant; 1997 Sep; 12 Suppl 2():75-81. PubMed ID: 9269706
    [Abstract] [Full Text] [Related]

  • 13. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 14. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S, Mahajan SK, Sen R, Sharma A.
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency.
    Abraham PA, Opsahl JA, Halstenson CE, Keane WF.
    Arch Intern Med; 1988 Nov; 148(11):2358-62. PubMed ID: 2847667
    [Abstract] [Full Text] [Related]

  • 16. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: a multicenter, randomized, double-blind, parallel-controlled, clinical trial.
    Mao G, Hong X, Xing H, Liu P, Liu H, Yu Y, Zhang S, Jiang S, Wang X, Xu X.
    Nutrition; 2008 May; 24(11-12):1088-96. PubMed ID: 18656328
    [Abstract] [Full Text] [Related]

  • 19. Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction.
    Reams GP, Bauer JH.
    Arch Intern Med; 1986 Nov; 146(11):2145-8. PubMed ID: 3022660
    [Abstract] [Full Text] [Related]

  • 20. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.